|
Volumn 3, Issue 4, 2001, Pages 247-252
|
Results of a phase-I/II randomized, masked, placebo-controlled trial of recombinant human interleukin-11 (rhIL-11) in the treatment of subjects with active rheumatoid arthritis
|
Author keywords
Cytokines; Interleukin 11; Rheumatoid arthritis
|
Indexed keywords
ANTIRHEUMATIC AGENT;
AUTACOID;
COCODAMOL;
CORTICOSTEROID;
CYCLOPHOSPHAMIDE;
CYCLOSPORIN;
CYTOKINE;
DEXTROPROPOXYPHENE;
INTERLEUKIN 11;
NITRIC OXIDE;
NONSTEROID ANTIINFLAMMATORY AGENT;
OXYCODONE;
PARACETAMOL;
PLACEBO;
RECOMBINANT INTERLEUKIN 11;
ABDOMINAL PAIN;
ADULT;
AGED;
ANIMAL MODEL;
ARTICLE;
ASTHENIA;
CELL GROWTH;
CELL MATURATION;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COUGHING;
DIARRHEA;
DISEASE ACTIVITY;
DISEASE ASSOCIATION;
DOSE RESPONSE;
DRUG ACTIVITY;
DRUG SAFETY;
DRUG TOLERABILITY;
DYSPEPSIA;
EDEMA;
FEMALE;
FLU LIKE SYNDROME;
HEADACHE;
HEMATOPOIETIC STEM CELL;
HISTOLOGY;
HUMAN;
INFECTION;
INJECTION SITE;
JOINT INJURY;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
NAUSEA;
PHARYNGITIS;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PLEIOTROPY;
RASH;
RHEUMATOID ARTHRITIS;
RHEUMATOLOGY;
RHINITIS;
SCORING SYSTEM;
SKIN MANIFESTATION;
SYNOVITIS;
TREATMENT FAILURE;
VERTIGO;
ADULT;
AGED;
AGED, 80 AND OVER;
ARTHRITIS, RHEUMATOID;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
INJECTIONS, SUBCUTANEOUS;
INTERLEUKIN-11;
JOINTS;
MALE;
MIDDLE AGED;
RECOMBINANT PROTEINS;
TREATMENT OUTCOME;
|
EID: 17844403234
PISSN: 14659905
EISSN: None
Source Type: Journal
DOI: 10.1186/ar309 Document Type: Article |
Times cited : (45)
|
References (16)
|